Abstract
The process of ageing is extremely variable in progression and phenotypic features including significant variations in disease milestones, such as cognitive impairment, frailty, or recurrent falls. Our aim was to analyze the influence of lifestyle factors on motor and cognitive performance in a longitudinal ageing study in older people on healthy ageing. We conducted a longitudinal analysis in a cohort of 744 older participants (mean 70 years) over an 8-year period. Cognitive performance was assessed using the Consortium to Establish a Registry for Alzheimer's Disease (CERADplus) test battery, including the Trail Making Test (TMT) for executive function. Gait performance was evaluated by measuring gait velocity. Dual-task performance was assessed by measuring gait velocity while checking boxes. Body Mass Index (BMI) was also recorded. Symptoms of depression were examined using Beck's Depression Inventory (BDI-II). We observed higher cognitive functions in individuals adhering to a high-frequency physical activity regimen and a resilient plant-based diet. Additionally, these individuals exhibited lower BDI-II scores and experienced mitigated cognitive decline. Participants who combined high physical activity, a high intake of plant-based foods, and extensive education-referred to as having a high "successful ageing index" -maintained nearly constant CERADplus total scores over the 8-year period. Protective lifestyle factors are linked to better cognitive and motor performance and a slower decline in cognitive function, indicating healthy ageing. Since the factors diet and exercise are modifiable, adopting them may enhance cognitive performance and autonomy in older adults.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | GeroScience |
| ISSN | 2509-2715 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 2025 |
Fördermittel
We have no conflict of interest to declare in regard to the manuscript. Prof. Daniela Berg has received grants or contracts from the German Research Society (DFG), German Parkinson’s Disease Association (dPV), Michael J Fox Foundation, BMBF, Parkinson Fonds Deutschland gGmbH, UCB Pharma GmbH, Novartis Pharma GmbH, Damp Foundation, and Lundbeck and has received speaker’s honoraria from AbbVie, Biogen, BIAL, UCB Pharma GmbH, and Novartis Pharma GmbH, outside the submitted work. She has served on advisory boards of Biogen, BIAL, UCB Pharma GmbH and AC Immune SA outside the submitted work. Prof. Kathrin Brockmann received Research Grants from the Michael J Fox Foundation for Parkinson’s Research (“LRRK2 Kinase Activity,” “Influence of Inflammatory Profiles on PD Phenotype and Progression,” “Prevent Dementia in GBA1-associated PD”), from the University of Tuebingen (“Endophenotyping of GBA1-PD”), from the German Society for Parkinson DPG, from the Health Forum Baden Wuerttemberg (“Predictive Diagnostic of immune-associated diseases for personalized medicine”), from the Else Kröner Fresenius Stiftung (“ClinBrain”), and from the German Research Foundation DFG (“CORO-TREND”). She serves on advisory boards for F. Hoffmann-La Roche Ltd and VanqaBio. She received speaker honoraria from Abbvie, Lundbeck, UCB, and Zambon. Prof. Gerhard Eschweiler has received research funding from the Innovationsfond (Fund of the Federal Joint Committee, Gemeinsamer Bundesausschuss, G-BA Grants No. VF1_2016-201). Prof. Andreas Fallgatter received grant support from the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), the Ministry for Science, Research and Art Baden-Württemberg (MWK), and the European Commission. Dr. Markus A. Hobert has nothing to disclose. Prof. Walter Maetzler receives or received funding from the European Union, the German Federal Ministry of Education of Research, German Research Council, Michael J. Fox Foundation, Robert Bosch Foundation, Neuroalliance, Lundbeck, Sivantos, and Janssen. He received speaker honoraria from Abbvie, Bayer, BIAL, GlaxoSmithKline, Heel, Licher MT, Rölke Pharma, Takeda, and UCB, and was invited to Advisory Boards/Consultancies of Abbvie, Aptar Digital Health, Atheneum, Biogen, Kyowa Kirin, Lundbeck, and Pfizer. He serves as an advisory board member of the Critical Path for Parkinson’s Consortium and the MDS e-Diary Working Group, and as an editorial board member of Geriatric Care. He is a member of the MDS Technology Working Group. Prof. Dr. Thomas Gasser serves on the editorial board of the Journal of Parkinson’s Disease. He holds a patent re: KASPP (LRRK2) gene, its production and use for the detection and treatment of neurodegenerative diseases. Prof. Gasser has received speaker’s honoraria from UCB Pharma, Novartis, Sanofi, and MedUpdate. He has received consulting fees from Bayer AG, BlueRock Therapeutics, and Biogen. He is Chairman of the Scientific Advisory Board of the “Joint Programming for Neurodegenerative Diseases” program, funded by the European Commission. He has received grant support from the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), the Ministry for Science, Research and Art Baden-Württemberg (MWK), the European Commission, the Helmholtz Association, and The Michael J. Fox Foundation. Dr. Stefanie Lerche has nothing to disclose. Dr. Benjamin Röben has received a research grant from the University of Tuebingen (Clinician Scientist; Project-Nr. 480–0-0). Claudia Schulte has nothing to disclose. Dr. Ulrike Sünkel has nothing to disclose. Dr. von Thaler, Anna-Katharina has nothing to disclose. Dr. Isabel Wurster receives funding from The Michael J. Fox Foundation (MJFF) as an Edmond J. Safra Fellow in Movement Disorders. Dr. Milan Zimmermann has received a research grant from the University of Tuebingen (Clinician Scientist; Project-Nr. 481–0-0).
| Träger | Trägernummer |
|---|---|
| Lundbeck | |
| Ministry for Science, Research and Art Baden-Württemberg | |
| German Federal Ministry of Education and Research | |
| Michael J. Fox Foundation | |
| Robert Bosch Foundation | |
| MWK | |
| Parkinson Fonds Deutschland gGmbH | |
| University of Tuebingen | |
| German Research Foundation | |
| Joint Programming for Neurodegenerative Diseases | |
| German Research Council | |
| German Society for Parkinson DPG | |
| Bundesministerium für Bildung und Forschung (BMBF) | |
| Michael J. Fox Foundation | |
| Else Kröner-Fresenius-Stiftung | |
| German Parkinson’s Disease Association | |
| Janssen | |
| German Research Society | |
| European Union | |
| Deutsche Forschungsgemeinschaft (DFG) | |
| German Federal Ministry of Education of Research | |
| European Commission | |
| German Research Foundation DFG | VF1_2016-201 |
| Helmholtz Association | 480–0-0 |
| MJFF | 481–0-0 |
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
-
SDG 10 – Weniger Ungleichheiten
Fingerprint
Untersuchen Sie die Forschungsthemen von „Impact of lifestyle factors on quantitative motor and cognitive performance: insights from a longitudinal study on healthy ageing“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver